Financials

  • Market Capitalization 2.67 M
  • Employee 9
  • Founded 2002
  • CEO N/A
  • Website www.arcadiabio.com
  • Headquarter Delaware, United States
  • FIGI BBG000GYBX66
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.15
Price to sales ratio
1.39
Dividends per share
Dividend yield %

Arcadia Biosciences Inc

Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation. It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.

Notícias